A Study to Evaluate Efficacy and Safety of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to Methotrexate (MTX) Treatment

NCT02305849 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

519

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Peficitinib
DRUG: Placebo
DRUG: Methotrexate

Sponsor

Astellas Pharma Inc